mRNA Variant Vaccines as a Second Boost: Results from the COVID-19 Variant Immunologic Landscape Trial

mRNA Variant Vaccines as a Second Boost: Results from the COVID-19 Variant Immunologic Landscape Trial

Explore the latest findings on mRNA variant vaccines as a second boost in this informative webinar presented by Dr. Nadine Rouphael, a renowned expert in vaccine research. Delve into the results of the COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial), which evaluates the safety and immunogenicity of SARS-CoV-2 variant vaccines. Gain insights into how protection from existing vaccines wanes over time and is affected by emerging variants, including Omicron subvariants. Learn about the potential of variant-specific boosters in addressing these challenges. This 17-minute presentation offers valuable information for healthcare professionals, researchers, and anyone interested in the latest developments in COVID-19 vaccine research.